摘要
目的:通过对比检测口腔鳞癌患者、良性颌面部肿瘤患者及健康对照者血清中的肥大细胞类胰蛋白酶(MCT)的表达水平,分析其在口腔鳞癌患者血清的表达水平有无异常,并分析其潜在的临床意义。方法:收集63例口腔鳞癌患者、47例颌面良性肿瘤患者及55例健康对照者的血清,用ELISA试剂盒检测血清中MCT的表达水平,后分析口腔鳞癌患者血清中MCT水平的临床意义。结果:口腔鳞癌患者血清中的MCT的表达水平高于其它两组,但不具有显著的统计学差异(P=0.09),而在口腔鳞癌组,MCT的浓度水平与肿瘤的大小呈正性相关,此外,在中分化鳞癌中MCT的表达水平相对较高。结论:MCT作为肥大细胞聚集、活化的标记物之一,在口腔鳞癌患者血清的表达并未显著升高,而血清MCT的表达水平与肿瘤大小有关。
Objective:To detect the expression level of mast cell tryptase(MCT)in serum of oral squamous cell carcinoma,benign maxillofacial cancer and healthy controls,and analyse its potential clinical significance in patients with OSCC.Methods:The serums from 63 case of OSCC,47 cases with maxillofacial benign tumor and 55 healthy controls were collected,and the MCT in serum was detected using MCT ELISA kit.Results:The MCT expression level in serum from patient with OSCC was higher than the other two groups,but without significant difference(P=0.09),and in cases with OSCC,MCT concentration levels was positively associated with tumor size,in addition,moderately differentiated OSCC had relatively higher expression levels of MCT.Conclusion:MCT,as an indicator of mast cell aggregation,activation,did not significantly increase in serum from OSCC patients,and the expression level of MCT was associated with tumor size.
出处
《口腔医学研究》
CAS
CSCD
2014年第12期1166-1168,共3页
Journal of Oral Science Research